This segment encompasses the core business of Diagnósticos da América S.A., providing a comprehensive range of clinical analysis and diagnostic imaging services. The company offers approximately 3,000 types of examinations, including laboratory tests, imaging services, and specialized diagnostics. Research and development activities focus on improving the accuracy, efficiency, and scope of diagnostic tests, including the adoption of advanced technologies like mass spectrometry for improved accuracy. The segment's impact is significant, as it provides crucial information for the diagnosis, treatment, and monitoring of various diseases. DASA's market positioning is strong in Brazil, with a focus on innovation and patient-centric care. Future opportunities include expansion of service offerings, integration of AI-powered diagnostic tools, and strategic partnerships to enhance its market presence. Regulatory compliance and clinical validation are critical aspects of this segment, ensuring the reliability and safety of diagnostic services.

This segment focuses on providing support services to approximately 5,000 laboratories under the Alvaro brand. These services include operational support, supply chain management, and access to advanced diagnostic technologies. Research and development efforts are directed towards optimizing laboratory workflows, improving efficiency, and reducing costs for partner laboratories. The segment's impact is seen in the improved quality and accessibility of diagnostic services across a wider network. DASA leverages its expertise and scale to provide competitive advantages to its partners. Future opportunities include expanding the network of partner laboratories, offering new services, and integrating digital solutions for improved laboratory management. Regulatory compliance and quality assurance are key considerations to ensure the reliability and accuracy of laboratory services provided through the Alvaro network.

This segment involves the provision of diagnostic services to the public sector under the CientíficaLab brand. This includes offering a range of clinical analysis and diagnostic imaging services to public hospitals and healthcare facilities. Research and development activities focus on adapting diagnostic technologies and services to meet the specific needs of the public healthcare system, including cost-effectiveness and accessibility. The segment's impact is significant in improving access to essential diagnostic services for a broader population. DASA's market positioning in this segment is driven by its ability to provide high-quality services at competitive prices. Future opportunities include expanding its presence in the public sector, offering specialized diagnostic services, and leveraging technology to improve efficiency and patient outcomes. Regulatory compliance and adherence to public health standards are critical aspects of this segment.